I have several clients that have transvaginal mesh cases against mesh manufacturers (assisted by Athens specialty firm of Blasingame, Burch, Garrard & Ashley, P.C.) and in April of 2011, I addressed the topic of
women suffering from pelvic pain, pelvic organ prolapse, and lifelong injuries because of surgical mesh. Pelvic organ prolapse occurs when the tissues holding the pelvic organs in place become weakened or stretched due to childbirth or other factors. In many cases, a mesh product will be implanted surgically to hold these organs in place.
In December of 2011, two medical groups, the American College of Obstetricians and Gynecologists (ACOG) and the American Urogynecologic Society (AUS) issued a joint opinion regarding transvaginal mesh surgery and urge patients to consider alternatives for the treatment of pelvic organ prolapse or "POP." The opinion recommends limiting the use of pelvic organ prolapse vaginal mesh repair to "high risk women for whom the benefit may justify the risk."
The Food and Drug Administration approved surgical mesh for pelvic organ prolapse repair in 2001 but issued a Public Health Notification in 2008 regarding serious complications. Based on updates and the numerous reported "adverse events" in women, the FDA issued a more forceful safety communication in July 2011, calling the use of transvaginal mesh for POP an "area of continuing serious concern." Further, the FDA has now stressed that the "serious complications associated with surgical mesh for transvaginal repair of POP are
not rare." (emphasis in original).
Doctors and patients considering mesh surgery should now consider every other alternative before proceeding. If the mesh surgery is absolutely necessary, the patient should insist on a copy of any and all information about the product and its manufacturer should there be complications after surgery.
Please contact me if you or a family member have suffered pain or injuries from a transvaginal mesh product implantation or other any other women's health product.